Detection of somatic β-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD)

Ítems similars

• mTOR pathway is activated by PKA in adrenocortical cells and participates in vivo to apoptosis resistance in primary pigmented nodular adrenocortical disease (PPNAD)
  per: de Joussineau, Cyrille, et al.
  Publicat: (2014)
• Detection of new potentially pathogenic mutations in two patients with primary pigmented nodular adrenocortical disease (PPNAD) — case reports with literature review
  per: Pasternak-Pietrzak, Katarzyna, et al.
  Publicat: (2018)
• Does Somatostatin Have a Role in the Regulation of Cortisol Secretion in Primary Pigmented Nodular Adrenocortical Disease (PPNAD)? A Clinical and in Vitro Investigation
  per: Bram, Zakariae, et al.
  Publicat: (2014)
• PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE (PPNAD) PRESENTING AS CUSHING SYNDROME IN A CHILD AND REVIEW OF LITERATURE
  per: Bavadiya, G., et al.
  Publicat: (2020)
• Primary pigmented nodular adrenocortical disease reveals insulin-like growth factor binding protein-2 regulation by protein kinase A
  per: Shi, Zonggao, et al.
  Publicat: (2007)